News
See the latest PIR International News, Articles and Network Updates.
PIR International Supports Appointment of Executive Chair at Dynamic42
PIR International was delighted to partner with Dynamic42 on the appointment of Wolfgang Kintzel as Executive Chair. Established in 2018, Dynamic42 is an innovative growth stage life science research tools company developing advanced three-dimensional organ-on-chip technology for preclinical research and [...]
PIR International Supports Appointment of Chief Business Officer at Slingshot Therapeutics
PIR International was delighted to partner with Slingshot Therapeutics on the appointment of Bobby Soni as Chief Business Officer. Slingshot Therapeutics provides an innovative platform with access to centralised expertise, resource, funding and operational support to accelerate exceptional academic science [...]
Rita Balice-Gordon – BioLeader Interview
Chief Executive Officer, Muna Therapeutics (July 2025) Rita Balice-Gordon, Ph.D., is the Chief Executive Officer of Muna Therapeutics, a global, early-stage biotech company focused on disease modifying therapies for neurodegenerative diseases. She is a Director on the Board of Collegium [...]
Bob Radie – BioLeader Interview
Chairman of the Board & Chief Executive Officer, Neuraptive Therapeutics (June 2025) Bob Radie has more than three decades of experience working in both public and private pharmaceutical and biotech companies. Having been involved in the launch of blockbuster antidepressant [...]